NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Prostate
; 79(1): 44-53, 2019 01.
Article
in En
| MEDLINE
| ID: mdl-30178500
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autophagy
/
Drug Resistance, Neoplasm
/
Tumor Suppressor Proteins
/
Prostatic Neoplasms, Castration-Resistant
/
Everolimus
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Prostate
Year:
2019
Type:
Article